| abstract |
The present invention provides a propellant-free aerosol pharmaceutical composition, which comprises a glycopyrronium pharmaceutically acceptable salt, indacaterol pharmaceutically acceptable salt, and water. The pharmaceutical composition contains glycopyrronium per 100 mL 0.045±0.001g to 0.090±0.001g, indacaterol 0.099±0.001g to 0.198±0.001g; the pharmaceutical composition is particularly suitable for forming an aerosol of the active substance by means of an atomizer in the symptoms of asthma and COPD The active agent is administered by inhalation. |